Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro.
It is investigated for its interactions with neurotrophic signalling pathways, gene expression and molecular processes associated with neuronal activity.
Research involving Semax includes the study of brain-derived neurotrophic factor (BDNF), intracellular signalling mechanisms and the biochemical regulation of neuropeptide-associated pathways.





